Lunglife AI Inc. is on the lookout for a strategic companion to assist get Lunglb — its non-invasive check for the early detection of lung most cancers — into the market and to the sufferers who want it. The corporate’s synthetic intelligence-supported blood-based check, which identifies indeterminate lung nodules, will probably be sport altering for early lung most cancers analysis, Paul Pagano, Lunglife CEO, informed BioWorld.
